Evaluation Of Safety, Tolerability And Pharmacokinetics Of Single And Multiple Doses Of PF-06730512
NCT03146065
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
79
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy
Interventions
BIOLOGICAL:
PF-06730512
DRUG:
Placebo
Sponsor
Pfizer